Social engagement
Social engagement: 370 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
Developer of immunotherapy for neurodegenerative disorders
Social engagement: 370 social following, 1 post in the last 12 months — below the industry typical range.
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |